Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

NIH Funds Drug-Resistant Malaria Therapy Trial

An agency of National Institutes of Health is funding a clinical trial of a new malaria drug engineered to overcome resistance developed to earlier treatments. . . . → Read More: NIH Funds Drug-Resistant Malaria Therapy Trial

Phones, Algorithms Boost Adherence to Stroke Meds

Results from a clinical trial show a smartphone-based remote monitoring program helps stroke patients stay on their blood clot medications and improve their health. . . . → Read More: Phones, Algorithms Boost Adherence to Stroke Meds

Umbilical Cord Blood Evaluated for Autism Treatment

Results from a clinical trial show infusions of a child’s own umbilical cord blood are safe for treating autism spectrum disorder, and provide initial signs of effectiveness. . . . → Read More: Umbilical Cord Blood Evaluated for Autism Treatment

Artificial Pancreas Shown Feasible for Young Children

An integrated system combining a glucose monitor and insulin pump to simulate the human pancreas is shown to be feasible for young children with type 1 diabetes. . . . → Read More: Artificial Pancreas Shown Feasible for Young Children

Triple-Drug Inhaler Shown to Cut COPD Attacks

Results from a year-long clinical trial show that an inhaler with three types of drugs reduces the number of COPD attacks compared to a common single-drug inhaler. . . . → Read More: Triple-Drug Inhaler Shown to Cut COPD Attacks

Zika DNA Vaccine Begins Clinical Trial

A new clinical trial is underway testing a Zika vaccine that uses genetically-engineered DNA to generate an immune response against the disease. . . . → Read More: Zika DNA Vaccine Begins Clinical Trial

FDA Approves Multiple Sclerosis Therapy

The Food and Drug Administration approved a synthetic targeted antibody to treat multiple sclerosis in people with relapsing or steadily worsening forms of the disease. . . . → Read More: FDA Approves Multiple Sclerosis Therapy

Trials, Registry Planned for Wound Care Device

A company making products for healing wounds is studying the ways one of its dressings is used in the field, to better understand the product’s role in wound care. . . . → Read More: Trials, Registry Planned for Wound Care Device

T-Cell Therapy Trial Begins for Autoimmune Diseases

A biotechnology company began testing on humans an experimental drug to increase healthy T-cells in the immune system for people with autoimmune disorders. . . . → Read More: T-Cell Therapy Trial Begins for Autoimmune Diseases

Inhaled Drug Shown Feasible for Postpartum Bleeding

Results from a clinical trial show a dry-powder inhaled form of the drug oxytocin works in the body much like the injected form, given to prevent postpartum hemorrhage, excessive bleeding in some women after childbirth. . . . → Read More: Inhaled Drug Shown Feasible for Postpartum Bleeding